Catalyst Wire Dossier Catalyst Wire Dossier

Technosphere Inhalation Powder

inhaled insulin · MannKind Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Technosphere Inhalation Powder, covering 2013-12-17 to 2013-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function [Phase 1]

See pricing